Arushi Khurana

17PUBLICATIONS
64CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 16, 2025
EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity.

Suheil Albert Atallah-Yunes, Thomas M Habermann, Matthew J Rees

|Apr 15, 2025
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.

Fateeha Furqan, Kwang W Ahn, Manmeet Kaur

|Feb 18, 2025
Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience.

Steven R Hwang, Richard C Godby, Brianna J Negaard

|Feb 07, 2025
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.

Samuel Yamshon, Jean L Koff, Melissa C Larson

|Sep 25, 2024
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.

Côme Bommier, Brian K Link, Brianna J Gysbers

|Jul 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL.

Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil

Pageof 3

Frequent Collaborators

8 joint publications

Yucai Wang

7 joint publications

Jonas Paludo

7 joint publications

Stephen M Ansell

6 joint publications

Thomas M Habermann